Recursion Pharmaceuticals, Inc. RXRX Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s other current assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported other current assets of $24.25M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s other current assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s other current assets decreased by 24.3% year-over-year, from $32.02M to $24.25M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s other current assets?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s other current assets has grown at a 67.7% compound annual growth rate (CAGR), from $2.16M to $28.57M.